1+ hour, 34+ min ago   (391+ words) Humedix posted record quarterly sales in the second quarter, driven by strong demand for its aesthetics products and increased orders for ophthalmic solutions. The aesthetics-focused affiliate of Huons Group said Friday that second-quarter sales on a standalone basis reached 50.4 billion…...

2+ hour, 24+ min ago   (1621+ words) Lee Jung-kue, founder and former CEO of Bridge Biotherapeutics, is re-emerging in the biotech industry again less than a year after stepping down from the company he led for nearly a decade. According to industry sources, Lee has emerged as…...

1+ day, 2+ hour ago   (315+ words) EuBiologics reported weaker first-half earnings this year as sales and operating profit fell from an unusually high base created by concentrated emergency cholera vaccine shipments a year earlier. The Korean vaccine maker said in its half-year report Thursday that revenue…...

1+ day, 8+ hour ago   (1054+ words) Kolmar Korea and Cosmax posted record quarterly sales and operating profit in the second quarter, as the global K-beauty boom continued to drive orders from Korean indie brands expanding across the U.S., Europe and other overseas markets. The strong results also…...

2+ day, 2+ hour ago   (425+ words) Shaperon is set to be designated an administrative issue on the Kosdaq as its shares remain far below the exchange’s new 1,000 won ($0.71) minimum-price threshold, while the biotech company is counting on a five-for-one share consolidation taking effect Sept. 8 to eventually…...

2+ day, 8+ hour ago   (455+ words) Celltrion is strengthening its foothold in Spain and Portugal through a string of public tender wins and growing uptake of its newly launched biosimilars, with its Xolair (omalizumab) biosimilar Omlyclo estimated to have captured more than 90 percent of the Spanish…...

3+ day, 2+ hour ago   (815+ words) Kolon Pharma is spinning off its drug development business to establish TonX BIO (pronounced "T-on-X Bio"), returning to an independent management structure three years after absorbing oncology drug developer FlatBio to bring its R&D capabilities in-house. The new company…...

3+ day, 2+ hour ago   (330+ words) Huons reported weaker second-quarter results from a year earlier, with sales and operating profit declining and net profit swinging to a loss amid the discontinuation of its continuous glucose monitoring business and a temporary suspension of U.S. exports. Huons said Tuesday…...

3+ day, 7+ hour ago   (156+ words) GC Cell said Monday that it has appointed Son Ju-hee as head of business development to strengthen its BD capabilities. Son graduated from Chungbuk National University’s College of Veterinary Medicine and earned a master’s degree in internal medicine. She later…...

4+ day, 48+ min ago   (487+ words) Korean RNA interference (RNAi) company OliX Pharmaceuticals said it has appointed Min Ji-young, a drug development expert with 20 years of experience in RNAi and nucleic acid therapeutics, as executive vice president and chief development officer (CDO). Min has worked across…...